[ADVERT]
Share Name Share Symbol Market Type
Selecta Biosciences Inc NASDAQ:SELB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.11 -3.73% 2.84 2.83 2.84 2.96 2.815 2.93 269,268 16:03:08

Selecta Biosciences Says FDA Puts Clinical Hold on SEL-302 Trial, Shares Lower

24/11/2021 11:23pm

Dow Jones News


Selecta Biosciences (NASDAQ:SELB)
Historical Stock Chart


From Oct 2021 to Nov 2021

Click Here for more Selecta Biosciences Charts.

By Stephen Nakrosis

 

Shares of biotechnology company Selecta Biosciences Inc. are trading lower in Wednesday's late-session, after the company said the U.S. Food and Drug Administration placed a clinical hold on its Phase 1/2 clinical trial of SEL-302 to treat patients with methylmalonic acidemia.

The company said SEL-302 consists of MMA-101 plus ImmTOR.

Selecta Biosciences also said on Nov. 23 it received a letter from the FDA "issuing a clinical hold in order to obtain additional information on the chemistry, manufacturing and controls related to the MMA-101 product candidate."

"Patient safety is our primary concern, and we are committed to addressing the FDA's questions regarding CMC as expeditiously as possible," said Carsten Brunn, president and chief executive.

At 5:35 p.m. ET, shares of Selecta Biosciences were trading 13.2% lower at $2.76 a share. Volume at the time topped 150,000 shares.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

November 24, 2021 18:08 ET (23:08 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Selecta Biosciences Chart

1 Year Selecta Biosciences Chart

1 Month Selecta Biosciences Chart

1 Month Selecta Biosciences Chart
ADVFN Advertorial
Your Recent History
NASDAQ
SELB
Selecta Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211130 16:18:15